Tumors of the Central Nervous System, Volume 1 Gliomas: Glioblastoma (Part 1) /

The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identificati...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Hayat, M. A. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Dordrecht : Springer Netherlands, 2011.
Σειρά:Tumors of the Central Nervous System ; 1
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02421nam a22005415i 4500
001 978-94-007-0344-5
003 DE-He213
005 20151201041624.0
007 cr nn 008mamaa
008 110815s2011 ne | s |||| 0|eng d
020 |a 9789400703445  |9 978-94-007-0344-5 
024 7 |a 10.1007/978-94-007-0344-5  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Tumors of the Central Nervous System, Volume 1  |h [electronic resource] :  |b Gliomas: Glioblastoma (Part 1) /  |c edited by M. A. Hayat. 
264 1 |a Dordrecht :  |b Springer Netherlands,  |c 2011. 
300 |a XXII, 434 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Tumors of the Central Nervous System ;  |v 1 
520 |a The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Neuroradiology. 
650 0 |a Oncology. 
650 0 |a Neurosurgery. 
650 0 |a Pathology. 
650 0 |a Surgery. 
650 1 4 |a Biomedicine. 
650 2 4 |a Cancer Research. 
650 2 4 |a Neuroradiology. 
650 2 4 |a Neurosurgery. 
650 2 4 |a Oncology. 
650 2 4 |a Pathology. 
650 2 4 |a Surgery. 
700 1 |a Hayat, M. A.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9789400703438 
830 0 |a Tumors of the Central Nervous System ;  |v 1 
856 4 0 |u http://dx.doi.org/10.1007/978-94-007-0344-5  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)